AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a $16.5 million outlay. Eli Lilly and Boehringer Ingelheim’s ...

These two policies could have major impacts on AbbVie, Lilly, and Johnson & Johnson. Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market ...

Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products in the U.S., they still import some drugs and ingredients used in the products. Steep pharmaceutical tariffs ...

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets. Specifically, it focuses on the use of disaccharides to ...

AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the Trump administration. On a conference call to discuss AbbVie's first ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. U.S. markets rebounded this week, fully recovering losses ...

Krzystek, who received a PhD in biological sciences from UB in 2022 and is now a senior scientist at AbbVie. "Kinases modify HTT and other transport components by attaching molecular tags to them ...

A measles alert sign hangs outside the entrance to the Cohen Children's Medical Center, where the state health department confirmed that a baby tested positive and that there is a possibility of ...